Market Herald logo

Subscribe

Be the first with the news that moves the market
  • ProMIS Neurosciences (PMN) will participate in the 2020 BIO CEO & Investor Conference in New York.
  • The company’s Executive Chairman, Eugene Williams, will give a presentation during the conference.
  • Mr Williams will present data which supports the company’s antibody program for neurodegenerative diseases.
  • ProMIS’s share price remains unchanged, with shares trading at $0.22 apiece.

Biotechnology company ProMIS Neurosciences (PMN) will send a representative to attend and participate in the 2020 BIO CEO & Investor Conference.

The 2-day long conference will be hosted at the Marriott Marquis Hotel in New York City.

The event will bring together investors, industry analysts, and senior executives from biotechnology and pharmaceutical companies like ProMIS.

The conference will take place on February 10th and 11th, with company presentations on both days.

The Executive Chairman of ProMIS, Eugene Williams, will give a presentation at 3:00pm (Eastern Time) on February 11th.

In his presentation, Mr Williams will present data that supports ProMIS’ antibody programs for targeting and treating neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and ALS.

Unfortunately, webcasting will not be available for the event.

ProMIS’s share price remains unchanged, with shares trading at $0.22 apiece.

More From The Market Herald

" LevelJump Healthcare (TSXV:JUMP) announces $2.5M private placement

LevelJump Healthcare (JUMP) will be conducting a non-brokered private placement financing for gross proceeds of up to $2,500,000.

" Leveljump Healthcare (TSXV:JUMP) provides corporate update

Leveljump Healthcare (JUMP) has agreed to acquire an additional minority interest in Real Time Medical (RTM), Shaw Lens, and Shaw Vision.

" PharmaDrug (CSE:PHRX) engages Octagon Media for an investor marketing campaign

PharmaDrug Inc. (PHRX) has engaged Octagon Media Corp to assist in a digital media advertising campaign coupled with an investor marketing program.

" Bloom Health Partners Inc. (CSE:BLMH) receives DTC eligibility

Common shares of Bloom Health Partners (BLMH) are now eligible for electronic clearing and settlement through the Depository Trust Company.